Get the Stockscreener App
0.00
100.00%
-3.49
After Hours:
3.42
3.42
+
Neoleukin Therapeutics Inc Stock (NLTX) Forecast
The Neoleukin Therapeutics Inc (NLTX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $11.51, representing a + increase from the current price of $0.00. The highest analyst price target is $13.32, and the lowest is $9.6947.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NLTX Price Target
Average 11.60
(+ Upside)
Is Neoleukin Therapeutics Inc (NLTX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 13.64 | Buy |
| STOCH(9,6) | 29.24 | Neutral |
| STOCHRSI(14) | 71.64 | Neutral |
| MACD(12,26) | -0.2568 | Sell |
| ADX(14) | 18.28 | Neutral |
| William %R | -100.00 | Buy |
| CCI(14) | -466.67 | Sell |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.106
Sell
|
2.8121
Sell
|
| MA20 |
3.2815
Sell
|
3.1072
Sell
|
| MA50 |
3.3869
Sell
|
3.0968
Sell
|
| MA100 |
2.4097
Sell
|
2.6147
Sell
|
| MA200 |
1.5937
Sell
|
1.8592
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, NLTX could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 12 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on NLTX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 13.64 indicates that NLTX is oversold. This indicates that NLTX price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 29.24 indicates that NLTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 71.64 indicates that NLTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 18.28 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -466.67 indicates that NLTX is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term NLTX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Neoleukin Therapeutics Inc financial reports and earnings history, Neoleukin Therapeutics Inc (NLTX) stock could reach $13.18 by 2030, $13.43 by 2040 and $9.1553 by 2050. See the projected annual prices until 2050 of the Neoleukin Therapeutics Inc stock below:
- Neoleukin Therapeutics Inc (NLTX) is expected to reach an average price of $10.40 in 2035, with a high prediction of $12.74 and a low estimate of $10.33. This indicates an $ rise from the last recorded price of $0.00.
- Neoleukin Therapeutics Inc (NLTX) stock is projected to chart a bullish course in 2040, with an average price target of $11.73, representing an $ surge from its current level. The forecast ranges from a conservative $10.83 to a sky-high $13.43.
- Our analysts predict Neoleukin Therapeutics Inc (NLTX) to jump by 2045, soaring from $9.2224 to an average price of $10.14, potentially reaching $11.47. While $9.2224 is the low estimate, the potential upside is significant.
- Neoleukin Therapeutics Inc (NLTX) stock is expected to climb by 2050, reaching an average of $7.969, a $ jump from its current level. However, a wide range of estimates exists, with high and low targets of $9.1553 and $7.1972, respectively, highlighting the market's uncertainty.
Neoleukin Therapeutics Inc Stock (NLTX) Year by Year Forecast
Neoleukin Therapeutics Inc Stock (NLTX) Price Forecast for 2024
Our forecast for NLTX stock price in 2024 now indicates an average price target of $9.9647 with a high forecast of $17.76 and a low forecast of $2.1717. The average prediction reflects an increase of + from the last recorded price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $9.9147 | $9.6947 | $13.32 | + |
| July, 2024 | $10.18 | $5.4353 | $10.69 | + |
| August, 2024 | $13.55 | $9.0959 | $14.45 | + |
| September, 2024 | $12.87 | $9.8865 | $14.28 | + |
| October, 2024 | $12.43 | $10.79 | $14.98 | + |
| November, 2024 | $13.63 | $11.94 | $17.76 | + |
| December, 2024 | $11.51 | $9.2587 | $15.18 | + |
Neoleukin Therapeutics Inc Stock (NLTX) Price Forecast for 2025
Neoleukin Therapeutics Inc Stock (NLTX) is expected to reach an average price of $13.20 in 2025, with a high prediction of $17.58 and a low estimate of $8.8268. This indicates an + rise from the last recorded price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $12.34 | $10.94 | $13.13 | + |
| February, 2025 | $11.24 | $10.75 | $13.95 | + |
| March, 2025 | $11.07 | $10.16 | $13.55 | + |
| April, 2025 | $12.15 | $9.7012 | $12.73 | + |
| May, 2025 | $12.02 | $11.39 | $13.48 | + |
| June, 2025 | $13.02 | $10.25 | $17.58 | + |
| July, 2025 | $12.11 | $11.98 | $14.53 | + |
| August, 2025 | $11.57 | $10.44 | $13.28 | + |
| September, 2025 | $11.60 | $10.68 | $12.93 | + |
| October, 2025 | $11.22 | $10.53 | $13.04 | + |
| November, 2025 | $9.4962 | $9.0162 | $11.37 | + |
| December, 2025 | $9.237 | $8.8268 | $10.74 | + |
Neoleukin Therapeutics Inc Stock (NLTX) Price Forecast for 2026
The predicted value for Neoleukin Therapeutics Inc (NLTX) in 2026 is set at an average of $4.8827. Estimates vary from a peak of $9.1971 to a trough of $0.5683, indicating an + surge from the present price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $6.6276 | $6.5576 | $9.1971 | + |
| February, 2026 | $7.4482 | $5.5881 | $7.6882 | + |
| March, 2026 | $6.909 | $6.5861 | $8.1188 | + |
| April, 2026 | $6.8596 | $6.1395 | $7.3792 | + |
| May, 2026 | $5.9802 | $5.6752 | $7.6526 | + |
| June, 2026 | $4.731 | $4.3006 | $5.9804 | + |
| July, 2026 | $3.7416 | $3.7016 | $5.3315 | + |
| August, 2026 | $2.9224 | $2.6821 | $4.0618 | + |
| September, 2026 | $2.223 | $2.0929 | $3.0426 | + |
| October, 2026 | $1.4637 | $1.4037 | $2.4432 | + |
| November, 2026 | $1.0144 | $0.9444 | $1.9641 | + |
| December, 2026 | $0.7051 | $0.5683 | $1.0348 | + |
Neoleukin Therapeutics Inc Stock (NLTX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Neoleukin Therapeutics Inc (NLTX) is $0.5062, with a high forecast of $0.9876 and a low forecast of $0.0247. This indicates an + increase from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.6557 | $0.4405 | $0.7857 | + |
| February, 2027 | $0.6364 | $0.5533 | $0.806 | + |
| March, 2027 | $0.6971 | $0.6066 | $0.9876 | + |
| April, 2027 | $0.6777 | $0.6172 | $0.8666 | + |
| May, 2027 | $0.2885 | $0.2685 | $0.748 | + |
| June, 2027 | $0.2473 | $0.1988 | $0.3487 | + |
| July, 2027 | $0.1238 | $0.0247 | $0.2493 | + |
| August, 2027 | $0.0859 | $0.0304 | $0.1622 | + |
| September, 2027 | $0.2349 | $0.0564 | $0.2911 | + |
| October, 2027 | $0.2419 | $0.1703 | $0.3113 | + |
| November, 2027 | $0.1644 | $0.143 | $0.314 | + |
| December, 2027 | $0.3532 | $0.1427 | $0.4122 | + |
Neoleukin Therapeutics Inc Stock (NLTX) Price Forecast for 2028
In 2028, Neoleukin Therapeutics Inc (NLTX) is projected to reach an average price of $2.0322, with a high projection of $3.798 and a low estimate of $0.2664. This indicates an + rise from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.5529 | $0.33 | $0.5839 | + |
| February, 2028 | $0.4546 | $0.4447 | $0.5622 | + |
| March, 2028 | $0.4262 | $0.395 | $0.5076 | + |
| April, 2028 | $0.3508 | $0.3058 | $0.5958 | + |
| May, 2028 | $0.4067 | $0.2664 | $0.4366 | + |
| June, 2028 | $0.4572 | $0.3169 | $0.5171 | + |
| July, 2028 | $3.268 | $0.3126 | $3.798 | + |
| August, 2028 | $3.0786 | $2.8583 | $3.3881 | + |
| September, 2028 | $2.92 | $2.70 | $3.159 | + |
| October, 2028 | $2.5916 | $1.7909 | $3.1903 | + |
| November, 2028 | $2.1128 | $1.8828 | $2.6617 | + |
| December, 2028 | $2.224 | $1.7934 | $2.3137 | + |
Neoleukin Therapeutics Inc Stock (NLTX) Price Forecast for 2029
The 2029 price forecast for Neoleukin Therapeutics Inc Stock (NLTX) is $9.7101 on average, with a high prediction of $17.39 and a low estimate of $2.0347. This represents an + increase from the previous price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $3.2956 | $2.0347 | $5.6253 | + |
| February, 2029 | $11.49 | $3.9959 | $12.65 | + |
| March, 2029 | $9.9031 | $7.2478 | $11.71 | + |
| April, 2029 | $8.9897 | $8.6997 | $12.95 | + |
| May, 2029 | $9.8009 | $5.0606 | $10.32 | + |
| June, 2029 | $13.18 | $8.7218 | $14.07 | + |
| July, 2029 | $12.49 | $9.5131 | $13.91 | + |
| August, 2029 | $12.05 | $10.41 | $14.60 | + |
| September, 2029 | $13.26 | $11.57 | $17.39 | + |
| October, 2029 | $11.14 | $8.8874 | $14.81 | + |
| November, 2029 | $11.97 | $10.57 | $12.76 | + |
| December, 2029 | $11.26 | $10.26 | $13.58 | + |
Neoleukin Therapeutics Inc Stock (NLTX) Price Forecast for 2030
Neoleukin Therapeutics Inc Stock (NLTX) is expected to reach an average price of $11.22 in 2030, with a high forecast of $17.21 and a low forecast of $5.2261. This signifies an + surge from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $10.70 | $9.7918 | $13.18 | + |
| February, 2030 | $11.78 | $9.3324 | $12.36 | + |
| March, 2030 | $11.65 | $11.02 | $13.11 | + |
| April, 2030 | $12.66 | $9.8849 | $17.21 | + |
| May, 2030 | $11.75 | $11.62 | $14.17 | + |
| June, 2030 | $11.21 | $10.08 | $12.92 | + |
| July, 2030 | $11.24 | $10.32 | $12.57 | + |
| August, 2030 | $10.85 | $10.16 | $12.67 | + |
| September, 2030 | $9.6727 | $8.6524 | $11.00 | + |
| October, 2030 | $8.8739 | $8.4636 | $10.13 | + |
| November, 2030 | $6.2652 | $6.1952 | $8.8343 | + |
| December, 2030 | $7.4267 | $5.2261 | $7.6567 | + |
1.62%
0.15%
Cap:
|
Volume (24h):